| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/08/1999 | WO1999016453A1 Method for the treatment of cystic fibrosis |
| 04/08/1999 | WO1999016422A1 Stabilized preparations for use in metered dose inhalers |
| 04/08/1999 | WO1999016421A1 Stabilized bioactive preparations and methods of use |
| 04/08/1999 | WO1999016420A1 Stabilized preparations for use in nebulizers |
| 04/08/1999 | WO1999016419A1 Perforated microparticles and methods of use |
| 04/08/1999 | WO1999003987A3 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 04/08/1999 | WO1999003882A3 Human leukocyte calcium activated potassium channel polypeptide |
| 04/08/1999 | CA2305140A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 04/08/1999 | CA2304482A1 Method for the treatment of cystic fibrosis |
| 04/08/1999 | CA2245924A1 A method of identifying agonists and antagonists for tumor necrosis related receptors tr1, tr3 and tr5 |
| 04/07/1999 | EP0906959A2 Aminopeptidase from Staphylococcus aureus |
| 04/07/1999 | EP0906955A2 FtsY |
| 04/07/1999 | EP0906286A1 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick |
| 04/07/1999 | EP0906108A1 Method of treating heart failure with endothelin antagonists |
| 04/07/1999 | EP0906102A1 A process for regulating vagal tone |
| 04/07/1999 | EP0906089A2 Buccal delivery system |
| 04/07/1999 | EP0770059B1 Substituted benzamidines, their production and their use as medicaments |
| 04/07/1999 | EP0647266B1 D-enzyme compositions and methods of their use |
| 04/07/1999 | EP0632033B1 Novel benzopyran derivative |
| 04/07/1999 | CN1213372A Heterocycle-condensed morphinoid derivatives (II) |
| 04/07/1999 | CN1213307A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213306A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213302A Preparation containing combination of N-5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and N-(4 trifluoromethylphenyl)-2-cyano-3-hyroxycrotonic acid amide |
| 04/06/1999 | US5892099 Autoimmune disease, bone disorders, liver damage, cardiovascular disorders |
| 04/06/1999 | US5892098 Inhibit activity of phosphodiesterase iv and production of tumor necrosis factor; treating asthma |
| 04/06/1999 | US5892045 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 04/06/1999 | US5892039 Piperazino derivatives as neurokinin antagonists |
| 04/06/1999 | US5891894 2-amino oxazole derivatives; antagonists of platelet activating factor useful in treatment of asthma, inflammation, cardiovascular disorders, renal diseases, or as contraceptives |
| 04/06/1999 | US5891893 5-amino-1,2,4-oxa(or thia)diazoles; antagonists of platelet activating factor useful in treatment of asthma, allergies, inflammation, cardiovascular diseases, renal diseases, or as contraceptives |
| 04/06/1999 | US5891878 Enzyme inhibitors of phosphodiesterase or tumor necrosis factor |
| 04/06/1999 | US5891852 Serine protease inhibitors-cycloheptane derivatives |
| 04/06/1999 | US5891844 Compositions for treating IRDS and ARDS with a combination of a Glucocorticosteroid and a lung surfactant, and their use |
| 04/06/1999 | US5891672 Polynucleotides encoding GTP cyclohydrolase II (ribA) |
| 04/06/1999 | CA2000804C Quinolyloxazole-2-ones useful as proteinkinase c inhibitors |
| 04/01/1999 | WO1999015670A1 LKTA DELETION MUTANT OF $i(P. HAEMOLYTICA) |
| 04/01/1999 | WO1999015656A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/01/1999 | WO1999015635A1 Human ste20-like stress activated serine/threonine kinase |
| 04/01/1999 | WO1999015553A2 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 04/01/1999 | WO1999015501A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents |
| 04/01/1999 | WO1999015493A1 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 04/01/1999 | WO1999015490A1 C3a receptor ligands |
| 04/01/1999 | WO1999015205A1 Immunization against streptococcus pneumoniae using conjugated and unconjugated pneumococcal polysaccharide vaccines |
| 04/01/1999 | WO1999015203A1 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms |
| 04/01/1999 | WO1999015183A1 PROTEASOME INHIBITORS, UBIQUITIN PATHWAY INHIBITORS OR AGENTS THAT INTERFERE WITH THE ACTIVATION OF NF-λB VIA THE UBIQUITIN PROTEASOME PATHWAY TO TREAT INFLAMMATORY AND AUTOIMMUNE DISEASES |
| 04/01/1999 | WO1999015182A1 New use for budesonide and formoterol |
| 04/01/1999 | WO1999015173A1 Compositions and methods for treating respiratory disorders |
| 04/01/1999 | WO1999015164A1 Amide derivatives for the treatment of diseases mediated by cytokines |
| 04/01/1999 | WO1999015035A1 Smoking products containing antioxidants |
| 04/01/1999 | WO1998056370A3 Therapeutic nanospheres |
| 04/01/1999 | DE19742263A1 Neue spezifische Immunophilin-Liganden als Antiasthmatika, Antiallergika, Antirheumatika, Immunsuppressiva, Antipsoriatika, Neuroprotektiva New specific immunophilin ligands as anti-asthmatics, anti-allergic, anti-inflammatory drugs, immunosuppressants, anti-psoriasis, neuroprotective agents |
| 04/01/1999 | CA2305350A1 Costimulating polypeptide of t cells, monoclonal antibodies, and the preparation and use thereof |
| 04/01/1999 | CA2304879A1 New tetracycles, process for their production and pharmaceutical preparations containing these compounds |
| 04/01/1999 | CA2304622A1 Proteasome inhibitors, ubiquitin pathway inhibitors or agents that interfere with the activation of nf-?b via the ubiquitin proteasome pathway to treat inflammatory and autoimmunediseases |
| 04/01/1999 | CA2304451A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents |
| 04/01/1999 | CA2304244A1 Immunization against streptococcus pneumoniae using conjugated and unconjugated pneumococcal polysaccharide vaccines |
| 04/01/1999 | CA2304162A1 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms |
| 04/01/1999 | CA2304005A1 Compositions and methods for treating respiratory disorders |
| 04/01/1999 | CA2303883A1 C3a receptor ligands |
| 04/01/1999 | CA2303863A1 Smoking products containing antioxidants |
| 04/01/1999 | CA2302936A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/01/1999 | CA2300051A1 Amide derivatives for the treatment of diseases mediated by cytokines |
| 04/01/1999 | CA2246004A1 A kringle-related clone, hthbz47 |
| 03/31/1999 | EP0905250A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA |
| 03/31/1999 | EP0905248A1 Staphylococcus aureus MurE protein and nucleic acids encoding it |
| 03/31/1999 | EP0905243A2 Polynucleotides from Staphylococcus aureus expressed in infected tissue |
| 03/31/1999 | EP0905139A2 5 ring heterocyles, process for preparation, use as inhibitors of leukocyte adhesion and pharmaceutical preparations comprising them |
| 03/31/1999 | EP0905133A1 Tetrazole derivatives as LTD4 and H1 antagonists |
| 03/31/1999 | EP0904374A1 Processed polypeptides with il-16 activity, process for preparing the same and their use |
| 03/31/1999 | EP0904293A1 An interleukin-5 antagonist |
| 03/31/1999 | EP0904266A1 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| 03/31/1999 | EP0904110A1 Nitric oxide donors capable of reducing toxicity from drugs |
| 03/31/1999 | EP0904108A1 METHODS FOR TREATMENT OF ALLERGIC DISEASES WITH IgE |
| 03/31/1999 | EP0904092A1 Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use |
| 03/31/1999 | EP0762886A4 Icam-1/lfa-1 short-chain peptides and method of using same |
| 03/31/1999 | CN1212689A Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 03/31/1999 | CN1212620A Mercapto derivatives as inhibitors of cyclooxygenases |
| 03/31/1999 | CN1212255A Biphenylsulfonyl cyanamides, process for their preparation, and their use as medicament |
| 03/31/1999 | CN1042730C Method for preparing pyrazolopyridine compound |
| 03/30/1999 | US5889178 N-(2,2-diphenylethyl)-derivatives |
| 03/30/1999 | US5889049 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 03/30/1999 | US5889024 Substituted heterocycles |
| 03/30/1999 | US5889014 Heterocyclic compounds for inhibiting phosphodiesterase IV |
| 03/30/1999 | US5889003 Phosphodiesterase inhibitor |
| 03/30/1999 | US5889002 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 03/30/1999 | US5888771 Gene products as targets for the development of antibiotics. |
| 03/30/1999 | US5888770 Spoiiie |
| 03/30/1999 | CA2093133C Synthetic lung surfactant |
| 03/25/1999 | WO1999014346A2 SENSE mRNA THERAPY |
| 03/25/1999 | WO1999014340A1 Human prl-1 phosphatase |
| 03/25/1999 | WO1999014242A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/25/1999 | WO1999014205A1 New 2-(3h)-oxazolone derivatives |
| 03/25/1999 | WO1999014196A1 Method for the synthesis of quinoline derivatives |
| 03/25/1999 | WO1999014195A1 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 03/25/1999 | WO1999013886A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications |
| 03/25/1999 | WO1999013885A1 Modulation of immune responses |
| 03/25/1999 | WO1999013867A1 Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol |
| 03/25/1999 | WO1998050032A9 BETA-LACTAM INHIBITORS OF CoA-IT |
| 03/25/1999 | WO1998048875A9 Method of delivering halotherapy |
| 03/25/1999 | DE19742014A1 Use of new and known tetracyclene compounds as phospholipase inhibitors |
| 03/25/1999 | CA2304982A1 Sense mrna therapy |